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1. Introduction
  Malaria remains the world’s most important tropical 
parasitic disease with about 40% of the world’s population 
still at risk of infection[1]. Although significant progress has 
been achieved in recent years at reducing malaria-related 
morbidity and mortality due to global malaria control 
measures, an estimated 216 million cases still occurred in 
2010 leading to about 655 000 deaths[2]. This figure may be 
an under-estimation as a recent study has suggested that 
the global burden of malaria may be larger than previously 
estimated, with about 1.24 million deaths in 2010[3]. 
  One durable achievement that could crown the current 
malaria control strategies will be the development of a 
universal effective malaria vaccine[4-7]. However, genetic 
diversity as well as antigenic variation in Plasmodium 
falciparum (P. falciparum) is a major obstacle in the 
development of an effective malaria vaccine as several of 
the intended P. falciparum vaccine candidate antigens are 
highly polymorphic[8-11]. Therefore, an understanding of 
parasite population genetic structure is necessary in order 
to comprehend the distribution and dynamics of natural 
parasite populations. It is also an important step towards 
the development or evaluation of malaria vaccines and in 
addition, it will serve as a benchmark against which control 
targets can be measured[7].
  The merozoite surface protein-2 (MSP-2), an abundant 
glycosyl-phosphatidylinositol (GPI)-anchored protein on the 
surface of P. falciparum merozoites, is a promising malaria 
vaccine candidate[12]. The MSP-2 gene is characterized 
by highly polymorphic central repeats flanked by unique 
variable domains and conserved N- and C- terminal 
domains. The gene is encoded by highly divergent alleles 
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grouped into two dimorphic families, FC27 and 3D7[13,14]. 
The extensive polymorphism in the MSP-2 gene makes it 
a useful molecular marker to characterize field isolates of
P. falciparum. 
  Malaria endemic areas are generally characterized by extensive 
parasite diversity[15-19]. Genetic diversity of P. falciparum
parasites increases the risk that an individual is infected 
with different parasite genotype and is an indicator of 
malaria transmission intensity. In high transmission 
areas, infected individuals often carry multiple parasite 
genotypes[20-22]. Conversely, the parasite population in low 
transmission areas has a limited genetic diversity and the 
majority of infections are monoclonal[23-25]. 
  Few studies have been carried out in south-western Nigeria 
to assess the extent of genetic diversity of P. falciparum
isolates[26-29] but there is dearth of information in the 
northern part of Nigeria. This study therefore, investigated 
the genetic diversity of P. falciparum isolates from naturally 
infected children in Lafia, North-central Nigeria. 
2. Materials and methods
2.1. Study area and participants 
  This study was conducted in Lafia, a city located in North-
central Nigeria. Lafia lies within the Nigeria’s Guinea 
savannah ecological zone as described earlier[30]. In Lafia, 
malaria is endemic and perennial with a 7-12 months 
transmission season[31]. Anopheles gambiae s.s., Anopheles 
arabiensis and Anopheles funestus are the predominant 
vectors in this region[32-34]. 
  Children aged one to eight years were enrolled into the 
study and assigned into one of two groups: asymptomatic 
or uncomplicated malaria group. Inclusion criteria for 
uncomplicated malaria group were presentation with 
symptoms compatible with malaria which includes chills, 
history of fever within the preceding 48 h or pyrexia at 
presentation (axillary temperature >37.5 曟), and the 
presence of asexual forms of P. falciparum in peripheral 
blood smears without any indication of complications. 
Children who lived in the same geographical area and 
resided within a 3 km radius of the hospital were enrolled 
into the asymptomatic group if they had P. falciparum 
infection, but no symptoms of malaria. 
  Ethical approval for the study was granted by the Ethics 
Review Committees of the Nasarawa State Ministry of Health 
as well as the Dalhatu Araf Specialist Hospital, Lafia. 
Informed consent was also obtained from parent or guardian 
of each child prior to being included in the study.
2.2. Sample collection and microscopy
  Blood (1 mL) was collected by venepuncture from each 
child into EDTA bottles for molecular, parasitological 
and haematological analysis. Three drops of blood were 
spotted on labelled filter paper, air dried, individually 
sealed in plastic bags and stored at room temperature until 
DNA extraction. Thick and thin blood smears were made 
for microscopic examination. The slides were labelled 
and allowed to dry. Slides were stained with freshly 
prepared Giemsa stain. Thick and thin blood films were 
then examined for malaria parasites. Parasitaemia were 
quantified relative to 250 white blood cells (WBC) on thick 
films and estimated as parasites per 毺L assuming a mean
WBC of 8 000/毺L of blood. Blood smears were labelled 
negative if no parasites were seen after examination of 200 
oil immersion fields (×1 000) on a thick blood film. 
2.3. DNA extraction and MSP-2 genotyping
  DNA was extracted from the dried blood spots on filter 
paper using the QIAamp® DNA Mini Kit (Qiagen, Hilden, 
Germany) following the manufacturer’s protocol, and stored 
at -20 曟 until further analysis. 150 毺L of distilled water 
was used to elute DNA. 
  All samples were genotyped for P. falciparum MSP-2 using 
the nested polymerase chain reaction (PCR) technique, in 
which the product of the primary reaction (outer) was used 
as template for the second reaction (nested). The primary 
reaction was designed to amplify the entire coding region 
of the MSP-2 gene using the MSP2-1 and MSA2-4 primer 
pairs (Table 1). The reaction mixture was performed in a 
final volume of 25 毺L containing 5.0 毺L of DNA template, 
2.5 毺L×10 reaction buffer, 100 毺M of each dNTPs (dATP, 
dGTP, dTTP, and dCTP), 0.75 units of Taq DNA polymerase 
and 0.5 pM of each primer. The PCR programme was: 
denaturation at 94 曟 for 5 min followed by 35 cycles of 10 s 
at 94 曟, 30 s at 57 曟 and 40 s at 72 曟 and a final extension 
period of 3 min at 72 曟. This was then followed by two sets 
of nested reactions using specific primers for FC27 and 
3D7 allelic families (Table 1). A third nested reaction was 
carried out using the MSP2-2 and MSP2-3 primers (Table 1), 
in order to assess the frequency of isolates which may test 
positive for MSP-2 but not specific for FC27 or 3D7 family 
due to the polymorphic nature of the central region. All 
nested reactions were performed in a final volume of 25 毺L
containing 2.0 毺L of PCR product from the primary reaction, 
2.5 毺L×10 reaction buffer, 100 毺M of each dNTPs, 0.5 pM 
of each primer and 0.75 units of Taq DNA polymerase. The 
PCR programme was: denaturation at 94 曟 for 5 s followed 
by 30 cycles of 10 s at 94 曟, 30 s at 57 曟 and 40 s at 72 曟
and a final extension period of 3 min at 72 曟. Allele-
specific positive controls and DNA-free negative controls 
were included in each set of reaction.
  PCR products were subjected to electrophoresis on 1.5% 
agarose gels and visualized by trans-illumination with 
ultraviolet light after staining with SYBR® Green. Fragment 
sizes were calculated relative to the standard size marker 
(100 bp DNA ladder) using the BioDocAnalyze (Biometra, 
Göttingen, Germany) computer software package.
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2.4. Statistical analysis
  Data were entered into Microsoft® Excel, 2002 (Microsoft 
Corporation) and analyzed using JMP Statistical Discovery 
Software version 5.0.1.2 (SAS Institute Inc.) and Stata 
version 9.2 (StataCorp, College Station, Texas). Normally 
distributed variables were compared using the Student’s 
t-test. Numerical data not conforming to normal distribution 
were log-transformed. The Chi-squared test was used to 
compare proportions or categorical variables. Multiplicity of 
infection (MOI), defined as the minimum number of distinct 
genotype per isolate, was calculated as the mean number of 
fragments per infected subject in each group. Spearman’s 
rank correlation coefficient was used to measure degree of 
association between variables Statistical significance was 
defined as P values <0.05.
3. Results
3.1. Baseline demographic data and parasitological indices
  A total of 320 children were enrolled into this study, 
comprising 140 with uncomplicated malaria and 180 
with asymptomatic infection. Of the 320 children that 
were enrolled into the study, 161 (50.3%) were males and 
159 (49.7%) were females. The median age of the study 
participants was 37 months. The levels of parasitaemia 
were significantly higher in the uncomplicated malaria 
group compared with the asymptomatic group (P<0.001). In 
asymptomatic children haemoglobin values were higher than 
in children with uncomplicated malaria (P<0.05). However, 
within the uncomplicated malaria group haemoglobin levels 
decreased with increasing parasite densities (r=-3.96; 
P<0.05). Other baseline parameters are shown in Table 2. 
3.2. Allelic diversity of P. falciparum MSP-2 gene
  The distribution of MSP-2 alleles in the different groups 
showed high genetic diversity of isolates in the study 
population as reflected in inter-allelic variability as 
well as intra-allelic length polymorphism (Figure 1). A 
total of 31 and 34 distinct MSP-2 alleles were found in 
the asymptomatic and uncomplicated malaria groups 
respectively (Table 3). The allelic frequency of FC27 type 
was higher in the asymptomatic malaria group (59%) 
compared with the uncomplicated malaria group (45%), 
while 3D7 alleles in the asymptomatic malaria group had 
a lower frequency (38%) compared with the uncomplicated 
malaria group (51%). A significant difference was found in 
the distribution of FC27 alleles and 3D7 alleles between 
the asymptomatic group and uncomplicated malaria group 
(P<0.05).
1 500 bp
600 bp
200 bp
Figure 1. Electrophoretic separation of PCR products showing intra-
allelic polymorphism in the FC27 allele type, as reflected both in 
the number of distinct fragments and in length polymorphisms of 
fragments. 
Lane M: 100 bp ladder. Lanes 1-18: parasite DNA from infected 
individuals showing mono- (lanes 1, 5, 7, 11 and 15) and multiple 
infections (lanes 4, 6, 9, 12, 13 and 18) as well as variation in number 
or repeat units.
  Multiplicity of infection was 2.1 (95% CI: 1.9-2.3) in the 
Table 1
Nucleotide sequence of primers used in this study.
Primer name                                   Nucleotide sequence
MSP 2-1 5’-ATG AAG GTA ATT AAA ACA TTG TCT ATT ATA-3’ 
MSP 2-4 5’-TTA TAT GAA TAT GGC AAA AGA TAA AAC AAG-3’ 
MSP 2-2 5’-ACA TTC ATA AAC AAT GCT TAT AAT ATG AGT-3’ 
MSP 2-3 5’- GAT TAT TTC TAG AAC CAT GCA TAT GTC CAT -3’ 
FC 27-1 5’-GCA AAT GAA GGT TCT AAT ACT AAT AG-3’ 
FC 27-2 5’-GCT TTG GGT CCT TCT TCA GTT GAT TC-3’ 
3D7-1 5’-GCA GAA AGT AAG CCT TCT ACT GGT GCT-3’ 
3D7-2 5’-GAT TTG TTT CGG CAT TAT TAT GA -3’
Table 2
Baseline characteristics of study participants (n=320).
AS (n=180) UM (n=140) P-value (AS vs UM) 
Mean age (months) 36.3依16.9*  38.5依18.8* >0.05
Sex (male/female) 93/87 68/72 -
Mean temperature (曟) 36.6依0.6* 37.8依1.0* <0.05
Mean haematocrit (%) 37.0依6.2* 32.0依5.7* <0.05
Parasite density (毺L) 893§ (118-6 720) 5 403§ (120-160 000)   <0.001
AS= Asymptomatic group; UM= Uncomplicated malaria group; *依Standard deviation in parentheses; §Geometric mean (range in parentheses).
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asymptomatic group whereas in the uncomplicated malaria 
group, multiplicity of infection was 2.0 (95% CI: 1.8-2.4). No 
difference was found statistically between the multiplicity 
of infection in the asymptomatic group and that of the 
uncomplicated malaria (P>0.05). 
  Clonality of infection, defined as the distinct number 
of clones or allelic fragment detected per child, ranged 
from 1 to 4 in the two study groups. Majority of children 
in the uncomplicated malaria group had one or two 
clonal infections, while most of the children with more 
than two distinguishable clonal infections were from 
the asymptomatic group. Polyclonality, defined as the 
percentage of isolates with more than one amplified PCR 
fragment, was found to be higher in the asymptomatic group 
(64%) than in the uncomplicated malaria (60%) group.
4. Discussion
  In malaria endemic regions, it is well established that 
infected individuals carry several complex mixture of 
parasite clones with different genetic and phenotypic 
characteristics[35-41]. This phenomenon appears to be 
important for the development of an efficient anti-malarial 
immunity which requires continuous exposure to a large 
number of parasite variants and malaria antigens. However, 
in some parts of Nigeria there is limited information on the 
parasites’ genetic profile. This study therefore, investigated 
the genetic complexity of P. falciparum parasites in children 
presenting with mild uncomplicated malaria as well as those 
with asymptomatic infection in north-central Nigeria. 
  In this study, a high genetic diversity of P. falciparum 
isolates was observed in the study population. This was 
reflected in the number of alleles found in the two study 
groups (31 and 34 in the asymptomatic and uncomplicated 
malaria group respectively). This is consistent with data from 
other areas with high malaria transmission such as in north-
eastern Tanzania[42], in Papua New Guinea[43], Ghana[44], 
Côte d’Ivoire[45] and Congo Brazzaville[46]. Analysis of allele 
prevalence revealed interesting trends. A higher prevalence 
of 3D7 allelic type was found in the uncomplicated malaria 
group (51%) compared to that found in the asymptomatic 
malaria group (38%). Likewise, the FC27 allelic type was 
more frequent in the asymptomatic group (59%) compared to 
the uncomplicated malaria group (45%). This may probably 
indicate a higher risk of developing symptomatic malaria 
with increasing carriage of isolates belonging to the 3D7 
allelic family. This observation is consistent with reports 
concerning clinical isolates from Senegal[15] as well as 
south-western Nigeria[27]. Similarly, in eastern Sudan, FC27 
genotype was noted to be over-represented in subjects 
with asymptomatic infections[47] comparable to what was 
found in the present study. Conversely, reports from other 
studies including north-eastern Tanzania[42], Benin[48] and 
Gabon[49,50], showed no evidence for association between 
a particular genotype and clinical outcome. The present 
result also contrasts with the observations made in Papua 
New Guinea where MSP-2 FC27 alleles were found to be 
associated with clinical malaria[51,52]. We have previously 
showed in South-western Nigeria, that the absence of FC27 
alleles was significantly associated with a 3.58-fold (95% 
CI=2.0-7.3) increased risk of developing uncomplicated 
malaria and a 5.9-fold (95% CI=2.2-9.6) increased risk of 
developing severe malaria[27]. There is need therefore, for 
a larger, multi-regional study to be conducted in order to 
ascertain whether the discrepancies reflect geographical 
differences in parasite populations or a genuine tendency for 
3D7 allelic types to be associated with clinical malaria.
  Data on monoclonal infections in this study showed that 
multiplicity of infections and polyclonality was higher in the 
asymptomatic group compared to the uncomplicated malaria 
group. This is consistent with data from other areas in Africa 
with comparable malaria transmission intensity where 
similarly high degree of multiple infections per infected 
individual with symptomatic malaria were demonstrated; 
such as in Senegal[53], Tanzania[54], Cameroon[55] as well as 
the Republic of Congo[46]. 
  Although the level of parasitaemia harboured was quite 
different between the two groups, there was a trend 
for reverse relationship between parasite density and 
complexity: uncomplicated malaria isolates had higher 
parasite density than those of asymptomatic group, yet 
their multiplicity of infection was lower. It may be that 
the diversity of asymptomatic P. falciparum infections, as 
evident in the high multiplicity of infection, contributes 
to protective malaria immunity in continuously exposed 
individuals especially in areas of perennial transmission[56].
  This study therefore, shows a high genetic diversity of 
P. falciparum isolates in north-central Nigeria and is 
comparable to similar reports from other high transmission 
areas. This information will serve as baseline data for 
evaluation of future malaria control interventions as well as 
for monitoring the parasite population structure. 
Table 3
Genetic diversity of P. falciparum isolates in the study population.
AS (n=180)  UM (n=140) P-value (AS vs UM)
No. of FC27 alleles (% frequency)       19 (59)       16 (45) <0.05
No. of 3D7 alleles (% frequency)       12 (38)       18 (51) <0.05
Total no. of alleles in each group 31 34
No. non-specific MSP-2 alleles   1   1
Multiplicity of infection      2.2      2.0 >0.05
Polyclonality (%) 62 60 >0.05
AS= Asymptomatic group; UM= Uncomplicated malaria group.
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